Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders

Table 4 p-values of the different concentrations of C-reactive protein and nerve growth factor in serum and urine samples

	CRP/Crea Urine	CRP/Crea Urine all	CRP Serum	NGF/Crea Urine	NGF Serum
Control Group vs Neurological Disorders	0.0020*	0.2510	0.0670	0.6119	0.6450
Control Group vs SC	0.5391	0.0118*	0.0181*	0.4334	0.9591
Control Group vs SC with micturition dysfunction	0.0009*	0.4010	0.1113	0.8546	0.6484
Neurological Disorders vs SC without micturition dysfunction	0.6997	0.0445*	0.4503	0.4712	0.7315
Neurological Disorders vs SC with micturition dysfunction	0.4033	0.3369	0.8576	0.7207	0.9778
SC without micturition dysfunction vs SC with micturition dysfunction	0.3961	0.2837	0.3401	0.4620	0.8298
Cystitis vs No cystits		0.0534		0.1112
Dogs unable to urinate vs Dogs with normal voiding		0.0778		0.7962

P-values of the different concentrations of C-reactive protein (CRP) and nerve growth factor (NGF) in serum and after normalizing to creatinine (CRP/ Crea; NGF/Crea) in urine samples for the different groups. Measurements including all CRP/Crea values are shown in the column “CRP/Crea urine all”. Calculations of samples only with detectable values are shown in the column “CRP/Crea Urine”. P-values comparing dogs with spinal cord disorders and associated micturition dysfunction with (cystitis) and without cystitis (no cystitis) and dogs regaining the ability to urinate (dogs with normal voiding) are shown in the last rows. Significances are highlighted with an asterisk (*).Spinal Cord disorders (SC)

ISSN: 1746-6148